![](/img/cover-not-exists.png)
Treatment of End-of-Dose Wearing-Off in Parkinson’s Disease: Stalevo® (Levodopa/Carbidopa/Entacapone) and Levodopa/DDCI Given in Combination with Comtess®/Comtan® (Entacapone) Provide Equivalent Improvements in Symptom Control Superior to That of Traditional Levodopa/DDCI Treatment
Brooks, D.J., Agid, Y., Eggert, K., Widner, H., Ø, stergaard, K., Holopainen, A.Volume:
53
Year:
2005
Language:
english
Journal:
European Neurology
DOI:
10.1159/000086479
File:
PDF, 133 KB
english, 2005